
Digital-Tier Strategy Improves Newborn Screening for Glutaric Aciduria Type 1.
A digital-tier strategy significantly reduces false positives in newborn screening for Glutaric Aciduria Type 1. ππΆ
Discover the newest research about AI innovations in 𧬠Rare Diseases.
A digital-tier strategy significantly reduces false positives in newborn screening for Glutaric Aciduria Type 1. ππΆ
AI is transforming drug discovery for rare diseases, addressing challenges in treatment options and diagnostics. ππ
AI enhances lipid nanoparticle design for gene therapy. Promising results in mRNA delivery to lungs and muscle. π¬οΈπ
Philips and Mayo Clinic collaborate to improve cardiac MRI using AI, enhancing efficiency and patient experience. π«π€
Salivary microbiota may aid in diagnosing persistent pulmonary nodules. Key biomarkers identified through advanced machine learning techniques. π¦ π
AI-generated images enhance diagnostic skills for chalazion and sebaceous carcinoma. Traditional lectures remain effective too. ππ€
A new study reveals a deep learning system for accurately diagnosing liver lesions in CT images. π€π©»
Explore BE-dataHIVE, a comprehensive database for base editing research. It supports precise gene editing with over 460,000 gRNA combinations. π§¬π
A new AI-based electro-stimulation system shows promise for aiding facial movements in patients with facial palsy. π€π‘
CT imaging plays a crucial role in assessing blood perfusion in hepatocellular carcinoma (HCC) for improved diagnosis and treatment. π©Ίπ